Petra Schweinhardt

Adjunct Professor

Alan Edwards Centre for Research on Pain
McGill University, Canada

petra.schweinhardt [at] (Email)

Dr. Schweinhardt was an Associate Professor in the Faculties of Dentistry and Medicine at McGill until 08/16. In September 2016, she took up a new appointment at the University of Zurich, Switzerland. Here is the link to her new web page.

At McGill, Dr. Schweinhardt held a Canada Research Chair (Tier II) in the Neurobiology of Chronic Pain Her research aimed at gaining a better understanding of the cerebral mechanisms of pain and pain modulation in health and disease, using neuropsychopharmacological and brain imaging techniques. Particularly, she investigated alterations that occur in the central nervous system of chronic pain patients; how these alterations interact with endogenous pain facilitatory or inhibitory circuitry and consequently contribute to the generation and maintenance of chronic pain. Dr. Schweinhardt’s research was supported by the Canadian Institutes of Health Research (CIHR), the Fonds de recherche du Québec – Santé (FRQS), the Louise and Alan Edwards Foundation, and two Pfizer Neuropathic Pain Awards.

Click here to watch on YouTube.



PUBLICATIONS 2015 / 2016

Original Articles

Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals.
Price RC, Christou NV, Backman SB, Stone L, Schweinhardt P.
Psychopharmacology (Berl). 2016 Sep 22. [Epub ahead of print]

Effects of topical combinations of clonidine and pentoxifylline on capsaicin-induced allodynia and postcapsaicin tourniquet-induced pain in healthy volunteers: a double-blind, randomized, controlled study.
Ragavendran JV, Laferrière A, Bennett GJ, Ware MA, Gandhi W, Bley K, Schweinhardt P, Coderre TJ.

Different Brain Circuitries Mediating Controllable and Uncontrollable Pain.
Bräscher AK, Becker S, Hoeppli ME, Schweinhardt P.
J Neurosci. 2016 May 4;36(18):5013-25. doi: 10.1523/JNEUROSCI.1954-15.2016.

Doubling Your Payoff: Winning Pain Relief Engages Endogenous Pain Inhibition(1,2,3).
Becker S, Gandhi W, Kwan S, Ahmed AK, Schweinhardt P.
eNeuro. 2015 Sep 17;2(4). pii: ENEURO.0029-15.2015. doi: 10.1523/ENEURO.0029-15.2015. eCollection 2015 Jul-Aug.

Increasing placebo responses over time in U.S. clinical trials of neuropathic pain.
Tuttle AH, Tohyama S, Ramsay T, Kimmelman J, Schweinhardt P, Bennett GJ, Mogil JS.
Pain. 2015 Dec;156(12):2616-26. doi: 10.1097/j.pain.0000000000000333. Review.

Is a Responsive Default Mode Network Required for Successful Working Memory Task Performance?
Čeko M, Gracely JL, Fitzcharles MA, Seminowicz DA, Schweinhardt P, Bushnell MC.
J Neurosci. 2015 Aug 19;35(33):11595-605. doi: 10.1523/JNEUROSCI.0264-15.2015.


Review Articles

Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction.
Taylor AM, Becker S, Schweinhardt P, Cahill C.
Pain. 2016 Jun;157(6):1194-8. doi: 10.1097/j.pain.0000000000000494.

Programmed symptoms: disparate effects united by purpose.
Gracely RH, Schweinhardt P.
Curr Rheumatol Rev. 2015;11(2):116-30.

Key mechanisms mediating fibromyalgia.
Gracely RH, Schweinhardt P.
Clin Exp Rheumatol. 2015 Jan-Feb;33(1 Suppl 88):S3-6. Epub 2015 Mar 17.